Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
August 30, 2014, 10:58:49 AM

Login with username, password and session length


Members
  • Total Members: 23346
  • Latest: izohar
Stats
  • Total Posts: 636642
  • Total Topics: 48321
  • Online Today: 179
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 4
Guests: 159
Total: 163

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Duke researchers hail new HIV/AIDS test  (Read 777 times)

0 Members and 1 Guest are viewing this topic.

Offline DanielMark

  • Member
  • Posts: 1,475
Duke researchers hail new HIV/AIDS test
« on: January 10, 2007, 07:01:35 AM »
Duke researchers hail new HIV/AIDS test
 
Updated: Tue. Jan. 9 2007

DURHAM, N.C. Detecting whether patients with HIV/AIDS are infected with even small amounts of drug-resistant forms of the virus can be done with a test developed by researchers at Duke University Medical Center.

While other tests only pick up drug-resistant strains when they represent a significant portion of the virus in a person's bloodstream, the test developed at Duke may enable doctors to more accurately predict which medicines will work for patients and which drugs will ultimately fail.

"This can be huge," said Dr. Feng Gao, a Duke HIV/AIDS researcher and co-author of the article published online Sunday in the journal Nature Methods.

So far, the test has been used for research purposes only. Duke is seeking patents that will enable it to develop a diagnostic screening for future commercial use.

A private industry backer is still needed, along with other studies that demonstrate the process helps improve treatment outcome.

Duke's new test comes amid rising evidence that HIV drug-resistance is a problem, even among patients who have never been treated with antiretroviral drugs. Studies have found that 15 percent or more of patients newly diagnosed with HIV harbor drug-resistant strains of the virus.

"A lot of questions are still unanswered, but it's an important step forward," said Dr. Peter Leone, an HIV/AIDS doctor at the University of North Carolina at Chapel Hill and medical director of the state's HIV prevention branch.

If the test pans out, Leone said, it would "improve the odds that the first course of treatment is going to be successful."

Even the less sensitive tests available now are helpful in avoiding treatment pitfalls, said Dr. Charles Hicks, a Duke infectious disease specialist who treats patients with HIV/AIDS and is co-author on the journal article.

He says a common mutant strain picked up by such tests resists one of the first-line treatments for HIV, and if patients test positive for that type of drug-resistant strain, doctors know to prescribe other medicines.

"It makes you choose a totally different treatment path," Hicks said.

Duke's test is more sensitive and detects resistant strains that make up less than 1 percent of the virus circulating in the patient's blood. With existing tests, drug-resistant HIV strains are picked up only if they make up 20 percent or more of the total virus in the patient's system.

"Even if you don't see resistance, you can't be sure that it's not really there," Hicks said. "That's a huge problem."
MEDS: REYATAZ & KIVEXA (SINCE AUG 2008)

MAY 2000 LAB RESULTS: CD4 678
VL STILL UNDETECTABLE

DIAGNOSED IN 1988

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.